Literature DB >> 17185042

Surveillance of methadone-related adverse drug events using multiple public health data sources.

Shannon A Sims1, Laverne A Snow, Christina A Porucznik.   

Abstract

Healthcare safety and quality surveillance is increasingly conducted by public health agencies. We describe a biomedical informatics method that uses multiple public health data sources to perform surveillance of methadone-related adverse drug events. Data from Utah medical examiner records, vital statistics, emergency department encounter administrative data and a database of controlled substances prescriptions are used to examine trends in state-wide adverse events related to methadone. From 1997 to 2004, population-adjusted methadone prescriptions increased 727%, with evidence to suggest the rise in the methadone prescription rate is for treatment of pain, not addiction therapy. During the same period of time, population adjusted, accidental methadone-related deaths in medical examiner data increased 1770%. Population adjusted methadone-related emergency department encounters rose 612% from 1997 to 2003. Our results suggest that the increase in methadone prescription rates from 1997 to 2004 was accompanied by a concurrent increase in methadone-related morbidity and mortality. Although patient data is not linked between data sources, our results demonstrate that utilizing multiple public health data sources captures more cases and provides more clinical detail than individual data sources alone. Our approach is a successful biomedical informatics approach for surveillance of adverse events and utilizes widely available public health data sources, as well as an emerging source of public health data, controlled substance prescription registries.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17185042     DOI: 10.1016/j.jbi.2006.10.004

Source DB:  PubMed          Journal:  J Biomed Inform        ISSN: 1532-0464            Impact factor:   6.317


  15 in total

1.  Lack of indinavir effects on methadone disposition despite inhibition of hepatic and intestinal cytochrome P4503A (CYP3A).

Authors:  Evan D Kharasch; Pamela Sheffels Bedynek; Christine Hoffer; Alysa Walker; Dale Whittington
Journal:  Anesthesiology       Date:  2012-02       Impact factor: 7.892

Review 2.  Informed consent in opioid therapy: a potential obligation and opportunity.

Authors:  Martin D Cheatle; Seddon R Savage
Journal:  J Pain Symptom Manage       Date:  2012-03-21       Impact factor: 3.612

Review 3.  Determinants of increased opioid-related mortality in the United States and Canada, 1990-2013: a systematic review.

Authors:  Nicholas B King; Veronique Fraser; Constantina Boikos; Robin Richardson; Sam Harper
Journal:  Am J Public Health       Date:  2014-06-12       Impact factor: 9.308

4.  Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 1: general population.

Authors:  Meldon Kahan; Angela Mailis-Gagnon; Lynn Wilson; Anita Srivastava
Journal:  Can Fam Physician       Date:  2011-11       Impact factor: 3.275

5.  Mechanism of ritonavir changes in methadone pharmacokinetics and pharmacodynamics: I. Evidence against CYP3A mediation of methadone clearance.

Authors:  E D Kharasch; P S Bedynek; S Park; D Whittington; A Walker; C Hoffer
Journal:  Clin Pharmacol Ther       Date:  2008-10       Impact factor: 6.875

6.  Regional and temporal variation in methamphetamine-related incidents: applications of spatial and temporal scan statistics.

Authors:  Daniel Sudakin; Laura E Power
Journal:  Clin Toxicol (Phila)       Date:  2009-03       Impact factor: 4.467

7.  Cytochrome P4503A does not mediate the interaction between methadone and ritonavir-lopinavir.

Authors:  Evan D Kharasch; Kristi Stubbert
Journal:  Drug Metab Dispos       Date:  2013-09-25       Impact factor: 3.922

8.  Mechanism of autoinduction of methadone N-demethylation in human hepatocytes.

Authors:  Scott D Campbell; Amanda Crafford; Brian L Williamson; Evan D Kharasch
Journal:  Anesth Analg       Date:  2013-06-03       Impact factor: 5.108

9.  Role of cytochrome P4502B6 in methadone metabolism and clearance.

Authors:  Evan D Kharasch; Kristi Stubbert
Journal:  J Clin Pharmacol       Date:  2013-01-07       Impact factor: 3.126

10.  Drug-induced torsades de pointes in an underserved urban population. Methadone: is there therapeutic equipoise?

Authors:  Jorge Romero; Samuel H Baldinger; David Goodman-Meza; Krysthel Engstrom; Carolina R Valencia; Anjani Golive; Francisco Medrano; Sabarivinoth Rangasamy; Mohammed Makkiya; John D Fisher; Jay Gross; Andrew Krumerman; Soo Kim; Mario J Garcia; Luigi Di Biase; Kevin J Ferrick
Journal:  J Interv Card Electrophysiol       Date:  2015-11-20       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.